The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Ebselen: prospective therapy for cerebral ischaemia
Abstract
Stroke occurs due to haemorrhage or occlusive injury and results in ischaemia and reperfusion injury. A variety of destructive mechanisms are involved including oxygen radical generation, calcium overload, cytotoxicity and apoptosis as well as the generation of inflammatory mediators. Ebselen, 2-phenyl-1, 2-benzisoselenazol-3(2H)-one (PZ 51, DR3305), is a mimic of GSH peroxidase which also reacts with peroxynitrite and can inhibit enzymes such as lipoxygenases, NO synthases, NADPH oxidase, protein kinase C and H(+)/K(+)-ATPase. Ebselen is in a late stage of development for the treatment of stroke. The molecular actions of ebselen contribute to its anti-inflammatory and anti-oxidant properties, which have been demonstrated in a variety of in vivo models. Numerous in vitro experiments using isolated LDL, liposomes, microsomes, isolated cells and organs have established that ebselen protects against oxidative challenge. Unlike many inorganic and aliphatic selenium compounds, ebselen has low toxicity as metabolism of the compound does not liberate the selenium moiety, which remains within the ring structure. Subsequent metabolism involves methylation, glucuronidation and hydroxylation. Experimental studies in rats and dogs have revealed that ebselen is able to inhibit both vasospasm and tissue damage in stroke models, which correlates with its inhibitory effects on oxidative processes. Results from randomised, placebo-controlled, double-blind clinical studies on the neurological consequences of acute ischaemic stroke, subarachnoid haemorrhage and acute middle cerebral artery occlusion, have revealed that ebselen significantly enhances outcome in patients who have experienced occlusive cerebral ischaemia of limited duration. The benefit achieved with ebselen is closely related to the rapidity with which the treatment is initiated, following the onset of the stroke attack. Safety and tolerability are good and no adverse effects have become apparent. Ebselen is currently at the pre-registration stage for subarachnoid haemorrhage and stroke in Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Selenium: Biochemical Role as a Component of Glutathione Peroxidase
Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., & Hoekstra, W. G. (1973) · Science · doi:10.1126/science.179.4073.588 · Cited by 7,809
Glutathione peroxidase: A selenoenzyme
Flohe, L., Günzler, W. A., & Schock, H. H. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80755-0 · Cited by 1,385
Tissue-specific functions of individual glutathione peroxidases
Brigelius-Flohé, R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00173-2 · Cited by 1,114
The selenoenzyme phospholipid hydroperoxide glutathione peroxidase
Ursini, F., Maiorino, M., & Gregolin, C. (1985) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(85)90182-5 · Cited by 990
A novel biologically active seleno-organic compound—1
Müller, A., Cadenas, E., Graf, P., & Sies, H. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90083-2 · Cited by 828
Self-citationOxygen radical mechanisms of brain injury following ischemia and reperfusion
Traystman, R. J., Kirsch, J. R., & Koehler, R. C. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.4.1185 · Cited by 653
A novel biologically active seleno-organic compound—II
Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., & Otter, R. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90084-4 · Cited by 433
Ebselen, a selenoorganic compound as glutathione peroxidase mimic
Sies, H. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90028-s · Cited by 431
Self-citationTuhrim, S., Horowitz, D. R., Sacher, M., & Godbold, J. H. (1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00045 · Cited by 430
Molecular actions of Ebselen—an antiinflammatory antioxidant
Schewe, T. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)00003-j · Cited by 428
Development of synthetic compounds with glutathione peroxidase activity
Wilson, S. R., Zucker, P. A., Huang, R. R. C., & Spector, A. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00197a065 · Cited by 413
Prostaglandin biosynthesis can be triggered by lipid peroxides
Hemler, M. E., Cook, H. W., & Lands, W. E. M. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90038-9 · Cited by 351
Protection against peroxynitrite
Arteel, G. E., Briviba, K., & Sies, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00073-3 · Cited by 305
Self-citationPathophysiology of acute ischaemic stroke
Pulsinelli, W. (1992) · The Lancet · doi:10.1016/0140-6736(92)90347-6 · Cited by 300
Peroxynitrite: an endogenous oxidizing and nitrating agent
Ducrocq, C., Blanchard, B., Pignatelli, B., & Ohshima, H. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050357 · Cited by 272
Saito, I., Asano, T., Sano, K., Takakura, K., Abe, H., Yoshimoto, T., Kikuchi, H., Ohta, T., & Ishibashi, S. (1998) · Neurosurgery · doi:10.1097/00006123-199802000-00038 · Cited by 257
Ebselen in Acute Middle Cerebral Artery Occlusion: A Placebo-Controlled, Double-Blind Clinical Trial
Ogawa, A., Yoshimoto, T., Kikuchi, H., Sano, K., Saito, I., Yamaguchi, T., Yasuhara, H., & for the Ebselen Study Group, &. (1999) · Cerebrovascular Diseases · doi:10.1159/000015908 · Cited by 208
Emerging treatments for stroke in humans
Koroshetz, W. J., & Moskowitz, M. A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10020-1 · Cited by 189
Expedient synthesis of ebselen and related compounds
Engman, L., & Hallberg, A. (1989) · The Journal of Organic Chemistry · doi:10.1021/jo00273a035 · Cited by 187
Oxidative Stress Developed During the Reperfusion of Ischemic Myocardium Induces Apoptosis
Maulik, N., Yoshida, T., & Das, D. K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00388-2 · Cited by 181
Kinetic study of the reaction of ebselen with peroxynitrite
Masumoto, H., Kissner, R., Koppenol, W. H., & Sies, H. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01237-9 · Cited by 171
Self-citationThe Reaction of Ebselen with Peroxynitrite
Masumoto, H., & Sies, H. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950115u · Cited by 171
Self-citationKinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51)
Maiorino, M., Roveri, A., Coassin, M., & Ursini, F. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90591-6 · Cited by 167
Takasago, T., Peters, E. E., Graham, D. I., Masayasu, H., & Macrae, I. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701426 · Cited by 161
Nitration and Hydroxylation of Phenolic Compounds by Peroxynitrite
Ramezanian, M. S., Padmaja, S., & Koppenol, W. H. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950135w · Cited by 157
Nunn, C. M., O’Neill, W. W., ROTHBAUM, D. A., Stone, G. W., O’Keefe, J. H., OVERLIE, P. A., Donohue, B. C., Grines, L. L., Browne, K. F., Vlietstra, R. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00622-6 · Cited by 156
Primary Structure of Human Plasma Glutathione Peroxidase Deduced from eDNA Sequences1
Takahashi, K., Akasaka, M., Yamamoto, Y., Kobayashi, C., Mizoguchi, J., & Koyaxna, J. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123172 · Cited by 153
Mechanism of the Catalytic Reduction of Hydroperoxides by Ebselen : A Selenium ‐ 77 Nmr Study
Fischer, H., & Dereu, N. L. M. (1987) · Bulletin des Sociétés Chimiques Belges · doi:10.1002/bscb.19870961006 · Cited by 148
Dawson, D. A., Masayasu, H., Graham, D. I., & Macrae, I. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11226-9 · Cited by 145
Über selenhaltige aromatische Verbindungen (VI)
Lesser, R., & Weiß, R. (1924) · Berichte der deutschen chemischen Gesellschaft (A and B Series) · doi:10.1002/cber.19240570703 · Cited by 111
Action of ebselen as an antioxidant against lipid peroxidation
Noguchi, N., Yoshida, Y., Kaneda, H., Yamamoto, Y., & Niki, E. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90035-h · Cited by 95
Schewe, C., SCHEWE, T., & Wendel, A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90224-0 · Cited by 90
Maiorino, M., Roveri, A., & Ursini, F. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90534-4 · Cited by 87
Cotgreave, I. A., Sandy, M. S., Berggren, M. I., Moldéus, P., & Smith, M. T. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90200-0 · Cited by 76
Morgenstern, R., Cotgreave, I. A., & Engman, L. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90122-2 · Cited by 75
Ebselen inhibition of apoptosis by reduction of peroxides
Ramakrishnan, N., Kalinich, J. F., & McClain, D. E. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00084-6 · Cited by 74
Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury
Ozaki, M., Nakamura, M., Teraoka, S., & Ota, K. (1997) · Transplant International · doi:10.1007/s001470050019 · Cited by 61
Interaction of ebselen with glutathione S-transferase and papain in vitro
Nikawa, T., Schuch, G., Wagner, G., & Sies, H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90411-1 · Cited by 54
Self-citationExcitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases
Scatton, B. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00392-0 · Cited by 49
Inhibitory Effects of Ebselen on Lipid Peroxidation in Rat Liver Microsomes
Hayashi, M., & Slater, T. F. (1986) · Free Radical Research Communications · doi:10.3109/10715768609088070 · Cited by 48
Ebselen Protects Mice Against T Cell-Dependent, TNF-Mediated Apoptotic Liver Injury
Tiegs, G., Küsters, S., Künstle, G., Hentze, H., Kiemer, A. K., & Wendel, A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37906-6 · Cited by 45
Ziegler, D. M., Gräf, P., Poulsen, L. L., Sies, H., & Stahl, W. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00026a004 · Cited by 33
Self-citationEbselen (DR3305) ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model
Watanabe, T., Nishiyama, M., Hori, T., Asano, T., Shimizut, T., & Masayasut, H. (1997) · Neurological Research · doi:10.1080/01616412.1997.11740859 · Cited by 26
Inhibition by Ebselen of microsomal NADPH-cytochrome P450-reductase but not
Wendel, A., Otter, R., & Tiegs, G. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90376-x · Cited by 24
Nikawa, T., Schuch, G., Wagner, G., & Sies, H. (1994) · PubMed · Cited by 10
Self-citationEffect of Ebselen on Contractile Responses in Perfused Rabbit Basilar Artery
Takase, T., Ohta, T., Ogawa, R., Tsuji, M., Tamura, Y., Kazuki, S., & Miyamoto, T. (1999) · Neurosurgery · doi:10.1097/00006123-199902000-00073 · Cited by 7
Cited by
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Chemistry of Biologically Important Synthetic Organoselenium Compounds
Mugesh, G., du Mont, W.-W., & Sies, H. (2001) · Chemical Reviews · doi:10.1021/cr000426w · Cited by 1,689
Self-citationNeuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Sulfur and Selenium: The Role of Oxidation State in Protein Structure and Function
Jacob, C., Giles, G. I., Giles, N. M., & Sies, H. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300573 · Cited by 756
Self-citationHanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Metadata
- Authors
- Parnham, M., & Sies, H.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa Healthcare
- Published
- 2000-03
- Volume
- 9
- Issue
- 3
- Pages
- 607-619
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2054877890
- Cited by
- 283
- References
- 47
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.